Risk Indicators of Sarcoidosis Evolution-Unified Protocol | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Risk Indicators of Sarcoidosis Evolution-Unified Protocol	Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, pulmonary sarcoidosis, respiratory system disorder, sarcoidosis	Recruiting	Not stated	2026-01-08		NCT05567133

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Heart, Lung, and Blood Institute (NHLBI)	791
University of California, San Francisco	637
University of Texas, Southwestern Medical Center at Dallas	11
Vanderbilt University Medical Center	299
Wayne State University	56

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Maryland	Baltimore	United States	86
UT Southwestern	Dallas	United States	33